Amanote Research
Register
Sign In
Rad52 Deficiency Decreases Development of Lung Squamous Cell Carcinomas by Enhancing Immuno-Surveillance
Oncotarget
- United States
doi 10.18632/oncotarget.16371
Full Text
Open PDF
Abstract
Available in
full text
Categories
Oncology
Date
March 18, 2017
Authors
Rachel Lieberman
Jing Pan
Qi Zhang
Ming You
Publisher
Impact Journals, LLC
Related search
SOX2 Is an Oncogene Activated by Recurrent 3q26.3 Amplifications in Human Lung Squamous Cell Carcinomas
PLoS ONE
Multidisciplinary
Overexpression of Thrombospondin-1 Decreases Angiogenesis and Inhibits the Growth of Human Cutaneous Squamous Cell Carcinomas
American Journal of Pathology
Forensic Medicine
Pathology
Non-Squamous Cell Carcinomas of the Larynx
Madridge Journal of Otorhinolaryngology
Gephyrin Suppresses Lung Squamous Cell Carcinoma Development by Reducing mTOR Pathway Activation
Cancer Management and Research
Oncology
Desmosomal Defects in Acantholytic Squamous Cell Carcinomas
Journal of Cutaneous Pathology
Dermatology
Forensic Medicine
Pathology
Histology
Metformin Prevents the Development of Oral Squamous Cell Carcinomas From Carcinogen-Induced Premalignant Lesions
Cancer Prevention Research
Medicine
Cancer Research
Oncology
HPV in Squamous Cell Carcinoma: An Immuno-Histochemical Study
Annals of the College of Medicine, Mosul
The Cytology of Squamous Cell Carcinomas in Domestic Animals
Journal of Veterinary Diagnostic Investigation
Veterinary
Studies on the Development of Squamous Cell Carcinoma of the Lung
Japanese Journal of Lung Cancer
Oncology
Respiratory Medicine
Pulmonary